Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Pfizer Inc. (NYSE: PFE) Seeking US Approval for COVID-19 Vaccine In…
Kintara Therapeutics (NASDAQ: KTRA) Posted Net Loss of $1.6 Per Share…
Turning Point Therapeutics Inc. (NASDAQ: TPTX) Receive Breakthrough Designation For Repotrectinib…
Timber Pharmaceuticals Inc. (NYSEAMERICAN: TMBR) Announce Encouraging Top-Line Results Evaluating TMB-001…
Brickell Biotech Inc. (NASDAQ: BBI) Release Encouraging Topline Results From Phase…
Finance
Altimmune Inc. (NASDAQ: ALT) Announces Promising First Phase Pemvidutide Study Results…
Ziopharm Oncology Inc. NASDAQ: ZIOP) Announce Strategic Reorganisation and Cash…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) Submits Clinical…
NovaBay Pharmaceuticals Inc. (NYSEAMERICAN: NBY) Signs Agreement To Acquire $15 Million…
Tonix Pharmaceuticals Holding Corp’s (NASDAQ: TNXP) Oral Presentation Accepted At ACR…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Moleculin Biotech Inc. (NASDAQ:MBRX)
Tag: Moleculin Biotech Inc. (NASDAQ:MBRX)
Moleculin Biotech Inc. (NASDAQ:MBRX) Granted Three Rare Paediatric Disease Designations For...
Ward Sport
-
December 4, 2020
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Receives Rare Paediatric Disease Designation For WP1066...
Matt Wade
-
December 3, 2020
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Enters Into an Agreement with Sterling Pharma...
Gavins Felicity
-
July 23, 2020
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Submits Expansion Request For Annamycin Study Sites...
Kate Hudson
-
June 15, 2020
0
Close
